Page 95 - Sohini Das

When will India finally have access to coronavirus vaccine?

India commands 40 per cent of global capacity for vaccines which is estimated at 5.7 billion doses

In the works: Priority list of who gets the Covid-19 vaccine first

Expert group preparing the list also in touch with both local and MNC vaccine makers

Govt sets ball rolling on NDHM, comes out with draft policy on health data

The provisions of this policy shall apply to the entities involved in the NDHM and those who are a part of the NDHE

Indian players in two minds about collaboration on Russian vaccine

Russia reached out to India, players are open to collaborate but seek clarity on data

Covid-19 drug sales shine even as domestic pharma market slows down

Major therapy areas show decline or low single-digit growth

Centre sets ball rolling on Covid vaccine procurement, may hold meet Monday

Health care experts said it was about time the government set the ball rolling for scaling up manufacturing because there would not be much time left after the world had a vaccine candidate

Fortis slips into red in Q1, posts loss before tax of Rs 208.26 crore

Total income during the quarter fell by 47 per cent to Rs 610 crore

Fortis to be renamed Parkway to distance itself from Singh brothers

License agreement of Fortis, SRL brands expire in 2021

Hyderabad-based Biological E joins hands with J&J for Covid-19 vaccine

The vaccine candidate is in phase 1/2a clinical trials

Covid-19: At Rs 2,800 per dose, Zydus launches cheapest remdesivir brand

Zydus plans to supply large quantities of the injectable drug in the market soon

Cipla tweaks management structure to mobilise second level of executives

Do these changes augur well for the future business growth plans? Analysts think so

India planning to create digital infra for distribution of Covid vaccine

A person close to the development said that of the various vaccine candidates under development now globally and in India, it is not yet clear how many shots would be required for each one

Mankind Pharma partners with South Korea's Daewoong for Covid drug

Will conduct clincial trials on anti-parasitic drug they claim is more effective than remdesivir

India weighs options in debate on who gets first shot of Covid-19 vaccine

Companies wait for government orders as top medical research group says health workers must get first inoculation

After showing signs of recovery in June, domestic pharma sales dip in July

Data shows that the Covid-19 crisis impacted the growth rate of the domestic market

Unique ID, data privacy give strength to Centre's digital health mission

Digitised health records could help collate and analyse data in a more comprehensive and 'real time' manner for policymaking

Serum Institute to provide Covid vaccine to 92 countries at Rs 250 a dose

Partners with Gavi, Gates Foundation, will provide 100 mn doses to Covax, a WHO initiative led by Gavi and CEPI

Cipla Q1 pre-tax profit jumps 20% to Rs 799 crore on strong revenues

Firm's domestic business did well, up 16% YoY during the quarter when Cipla launched licensed version of Gilead's remdesivir

How Mumbai raced to add more beds than patients after its June unlocking

Nearly half the bed capacity lies unutilised now

Coronavirus fears lead to sudden spike in pneumonia vaccine sales

many people have become sensitised to adult vaccination in the country as we await the first vaccine candidate against the SARS-CoV-2 virus